Nimed (Nimesulide)

Nimesulide blocks the cyclooxygenase‑2 enzyme, which lowers prostaglandin production at sites of inflammation. By reducing these inflammatory mediators, it diminishes pain, swelling, and fever without markedly affecting COX‑1 related gastric protection.

The specific dose and frequency of Nimed are determined by the prescribing clinician based on the patient’s condition, severity, and response. Healthcare professionals tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

Nimed is generally avoided in pregnancy and lactation unless the potential benefit justifies the risk. Limited safety data exist, so clinicians usually recommend alternative therapies for pregnant or nursing individuals.

To request Nimed, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nimed’s selective COX‑2 inhibition offers analgesic and anti‑inflammatory benefits similar to other NSAIDs but may present a lower risk of gastric irritation. However, it still carries potential hepatic and cardiovascular risks that differ from non‑selective NSAIDs, so choice depends on individual patient factors.

Store Nimed at temperatures below 25 °C in its original container. Protect it from moisture, direct sunlight, and extreme heat to maintain product stability and efficacy.

Nimed is a cutaneous preparation applied to the skin over the affected area. The prescriber will advise the amount to use, frequency of application, and duration of therapy based on the patient’s specific condition.

Serious adverse events include severe allergic reactions such as Stevens‑Johnson syndrome, hepatotoxicity manifesting as jaundice or elevated liver enzymes, and rare cardiovascular complications like hypertension or thrombotic events. Immediate medical attention is required if these occur.

Patients with known hypersensitivity to nimesulide or other NSAIDs, those with active liver disease, severe renal impairment, uncontrolled hypertension, or a history of serious cardiovascular events should avoid Nimed unless a specialist determines it is essential.